• SPX
  • $5,699.94
  • -0.17 %
  • -$9.60
  • DJI
  • $42,011.59
  • -0.44 %
  • -$184.93
  • N225
  • $38,732.41
  • 0.47 %
  • $180.35
  • FTSE
  • $8,282.52
  • -0.1 %
  • -$8.34
  • IXIC
  • $17,918.48
  • -0.04 %
  • -$6.65
Biodesix, Inc. (BDSX) Stock Price, News & Analysis

Biodesix, Inc. (BDSX) Stock Price, News & Analysis

Currency in USD Disclaimer

$1.70

-$0.05

(-2.86%)

Day's range
$1.68
Day's range
$1.75
50-day range
$1.47
Day's range
$2.04
  • Country: US
  • ISIN: US09075X1081
52 wk range
$1.15
Day's range
$2.21


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -3.57
  • Piotroski Score 4.00
  • Grade Buy
  • Symbol (BDSX)
  • Company Biodesix, Inc.
  • Price $1.70
  • Changes Percentage (-2.86%)
  • Change -$0.05
  • Day Low $1.68
  • Day High $1.75
  • Year High $2.21

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also offers GeneStrat ddPCR and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions; and GeneStrat NGS (NGS) test, a 72-hour blood-based NGS test. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc. was incorporated in 2005 and is headquartered in Boulder, Colorado.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/04/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $3.00
  • High Stock Price Target $3.00
  • Low Stock Price Target $3.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.54
  • Trailing P/E Ratio -2.46
  • Forward P/E Ratio -2.46
  • P/E Growth -2.46
  • Net Income $-52,146,000

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.